Ascendis Pharma A (ASND) Current Taxes (2012 - 2026)
Ascendis Pharma A (ASND) posted Current Taxes of $9.1 million for Q1 2026, up 22.14% sequentially from $7.5 million in Q4 2025, and up 452.25% YoY from $1.7 million in Q1 2025.
Ascendis Pharma A (ASND) Current Taxes (2012 - 2026) Analysis & Trends
Ascendis Pharma A has reported Current Taxes for 13 years, with the latest figure at $9.1 million in Q1 2026.
- Quarterly Current Taxes rose 452.25% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 452.25% YoY) and the FY2025 annual result came in at $7.5 million, up 472.92% from the prior year.
- Current Taxes rose to $9.1 million in Q1 2026 per ASND's latest filing, from $7.5 million in the prior quarter.
- Over five years, Current Taxes peaked at $9.1 million in Q1 2026 and troughed at $96035.1 in Q2 2022.
- A 5-year average of $3.4 million and a median of $1.9 million in 2025 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2023 and 2024: Current Taxes soared 6445.9% in 2023, then sank 84.18% in 2024.
- Over 5 years, Current Taxes stood at $5.6 million in 2022, then plunged by 55.84% to $2.5 million in 2023, then sank by 47.21% to $1.3 million in 2024, then jumped by 472.92% to $7.5 million in 2025, then increased by 22.14% to $9.1 million in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $9.1 million, $7.5 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | 9.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.14 Mn |
| Dec 31, 2025 | 7.48 Mn |
| Sep 30, 2025 | 1.88 Mn |
| Jun 30, 2025 | 804,823.34 |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 2.47 Mn |
| Sep 30, 2023 | 7.05 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | 7.38 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | 127,042.57 |
| Jun 30, 2022 | 96,035.10 |
| Mar 31, 2022 | 560,046.52 |
| Dec 31, 2021 | 226,506.25 |
| Sep 30, 2021 | 590,822.95 |
| Jun 30, 2021 | 454,010.33 |